Who Supplies Dasatinib? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Dasatinib exports, with 110+ registered manufacturers shipping to buyers across 71+ countries — yet a handful of companies dominate the shipments. DR.REDDY'S LABORATORIES LTD holds the largest share at 15.4% (export value: $2.5M). Close behind, MSN LABORATORIES PRIVATE LIMITED (14.0%, $2.3M). EUGIA PHARMA SPECIALITIES LIMITED (13.3%, $2.2M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Dasatinib? Top Manufacturers & Their Buyers
Flow of Dasatinib from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Dasatinib Supplier Network — Key Market Intelligence
The Dasatinib export market from India is led by DR.REDDY'S LABORATORIES LTD, which alone commands a 15.4% share, shipping $2.5M worth of product across 42 shipments. The second-largest exporter, MSN LABORATORIES PRIVATE LIMITED, contributes $2.3M (14.0%) to the overall market. Combined, the top two suppliers alone account for 29.4% of all Dasatinib exports, indicating a relatively concentrated supply base.
Across all 110 tracked manufacturers, the total Dasatinib export value stands at $16.4M from 508 shipments. The market average shipment value is $32.3K. The single largest buyer relationship in terms of trade value is TARO PHARMACEUTICALS INC, receiving $1.7M worth of product.
The combined buyer network spans 18 named purchasing companies, including DR REDDYS LABORARORIES, INC, DR. REDDYS LABORATORIES CANADA INC, DR.REDDY,S LABORATORIES (PTY) LIMIT, DR REDDY S LABORATOR, DR.REDDY S FARMACEUT and 13 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1DR.REDDY'S LABORATORIES LTD
DR.REDDY'S LABORATORIES LTD is the first-largest Dasatinib exporter from India, with a market share of 15.4% and a total export value of $2.5M across 42 shipments. Their average shipment value of $59.9K is above the market average of $32.3K, suggesting premium or bulk contract pricing.
DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. DR REDDYS LABORARORIES, INC is the dominant customer, accounting for 63.8% of this supplier's tracked business. Top customers include:
• DR REDDYS LABORARORIES, INC — $1.6M across 27 shipments (63.8% of this supplier's total exports)
• DR. REDDYS LABORATORIES CANADA INC — $300.6K across 5 shipments (11.9% of this supplier's total exports)
• DR.REDDY,S LABORATORIES (PTY) LIMIT — $299.0K across 5 shipments (11.9% of this supplier's total exports)
• DR REDDY S LABORATOR — $169.1K across 3 shipments (6.7% of this supplier's total exports)
• DR.REDDY S FARMACEUT — $141.8K across 2 shipments (5.6% of this supplier's total exports)
Key Insight: DR.REDDY'S LABORATORIES LTD's per-shipment value of $59.9K is 86% above the market average of $32.3K, consistent with large-order contracts or value-added formulations.
2MSN LABORATORIES PRIVATE LIMITED
MSN LABORATORIES PRIVATE LIMITED is the second-largest Dasatinib exporter from India, with a market share of 14.0% and a total export value of $2.3M across 52 shipments. Their average shipment value of $44.1K is above the market average of $32.3K, suggesting premium or bulk contract pricing.
MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. MSN LIFE CARE SA DE CVRFC MLC170629 is the dominant customer, accounting for 73.9% of this supplier's tracked business. Top customers include:
• MSN LIFE CARE SA DE CVRFC MLC170629 — $1.7M across 38 shipments (73.9% of this supplier's total exports)
• MSN LABS PERU SAC — $310.4K across 7 shipments (13.5% of this supplier's total exports)
• BOSTON ONCOLOGY ARABIA — $222.3K across 5 shipments (9.7% of this supplier's total exports)
• SANDOZ PTY LTD — $41.9K across 1 shipments (1.8% of this supplier's total exports)
• PHARMADOX HEALTHCARE — $23.2K across 1 shipments (1.0% of this supplier's total exports)
Key Insight: MSN LABORATORIES PRIVATE LIMITED's per-shipment value of $44.1K is 37% above the market average of $32.3K, consistent with large-order contracts or value-added formulations.
3EUGIA PHARMA SPECIALITIES LIMITED
EUGIA PHARMA SPECIALITIES LIMITED is the third-largest Dasatinib exporter from India, with a market share of 13.3% and a total export value of $2.2M across 9 shipments. Their average shipment value of $241.9K is above the market average of $32.3K, suggesting premium or bulk contract pricing.
EUGIA PHARMA SPECIALITIES LIMITED serves 2 named buyers in our database. AUROBINDO PHARMA USA., INC, is the dominant customer, accounting for 71.6% of this supplier's tracked business. Top customers include:
• AUROBINDO PHARMA USA., INC, — $1.6M across 6 shipments (71.6% of this supplier's total exports)
• AUROBINDO PHARMA USA., INC, — $617.6K across 3 shipments (28.4% of this supplier's total exports)
Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $241.9K is 650% above the market average of $32.3K, consistent with large-order contracts or value-added formulations.
4SUN PHARMACEUTICAL INDUSTRIES LTD
SUN PHARMACEUTICAL INDUSTRIES LTD is the fourth-largest Dasatinib exporter from India, with a market share of 12.0% and a total export value of $2.0M across 9 shipments. Their average shipment value of $218.7K is above the market average of $32.3K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LTD serves 2 named buyers in our database. TARO PHARMACEUTICALS INC is the dominant customer, accounting for 87.0% of this supplier's tracked business. Top customers include:
• TARO PHARMACEUTICALS INC — $1.7M across 8 shipments (87.0% of this supplier's total exports)
• SUN PHARMA ANZ PTY LTD — $255.3K across 1 shipments (13.0% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LTD's per-shipment value of $218.7K is 578% above the market average of $32.3K, consistent with large-order contracts or value-added formulations.
5DR REDDY S LABORATORIES LTD
DR REDDY S LABORATORIES LTD is the fifth-largest Dasatinib exporter from India, with a market share of 9.0% and a total export value of $1.5M across 9 shipments. Their average shipment value of $164.5K is above the market average of $32.3K, suggesting premium or bulk contract pricing.
DR REDDY S LABORATORIES LTD serves 2 named buyers in our database. DR REDDYS LABORATORIES CANADA INC is the dominant customer, accounting for 95.3% of this supplier's tracked business. Top customers include:
• DR REDDYS LABORATORIES CANADA INC — $1.4M across 9 shipments (95.3% of this supplier's total exports)
• DR REDDY S FARMACEUT — $70.1K across 0 shipments (4.7% of this supplier's total exports)
Key Insight: DR REDDY S LABORATORIES LTD's per-shipment value of $164.5K is 410% above the market average of $32.3K, consistent with large-order contracts or value-added formulations.
6SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Dasatinib exporter from India, with a market share of 5.4% and a total export value of $878.2K across 36 shipments. Their average shipment value of $24.4K is below the market average of $32.3K, reflecting a high-volume, competitive pricing strategy.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. SUN PHARMA ANZ PTY LTD is the dominant customer, accounting for 77.7% of this supplier's tracked business. Top customers include:
• SUN PHARMA ANZ PTY LTD — $682.5K across 28 shipments (77.7% of this supplier's total exports)
• SUN PHARMA ANZ PTY LTD — $125.6K across 5 shipments (14.3% of this supplier's total exports)
• SUN PHARMA PHILIPPIN — $37.6K across 2 shipments (4.3% of this supplier's total exports)
• SUN PHARMACEUTICAL I — $32.5K across 1 shipments (3.7% of this supplier's total exports)
• RANBAXY PHARMACEUTIC — $16 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (36 shipments) at a per-shipment value of $24.4K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Dasatinib Flows
Once Dasatinib leaves the manufacturing plants of companies like DR.REDDY'S LABORATORIES LTD and MSN LABORATORIES PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $16.4M. United States absorbs the largest share at 31.7% ($5.2M), followed by Canada (20.1%) and Australia (12.9%).
In United States — the top destination — named importers include DR REDDYS LABORARORIES, INC, AUROBINDO PHARMA USA INC, DR REDDYS LABORATORIES INC. In Canada, key buyers are TARO PHARMACEUTICALS INC, DR REDDYS LABORATORIES CANADA INC, DR. REDDYS LABORATORIES CANADA INC.
This geographic spread reflects Dasatinib's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Dasatinib Go? Top Importing Countries & Their Buyers
Trade flow of Dasatinib exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Dasatinib imports from India, with a total trade value of $5.2M across 21 shipments — representing a 31.7% share of all Dasatinib exports. The average shipment value of $247.4K is above the global average of $32.3K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Dasatinib importers in United States: DR REDDYS LABORARORIES, INC is the largest buyer, accounting for 30.9% ($1.6M) of this market's total imports.
• DR REDDYS LABORARORIES, INC — $1.6M (30.9% of United States's total)
• AUROBINDO PHARMA USA INC — $1.6M (30.0% of United States's total)
• DR REDDYS LABORATORIES INC — $1.4M (27.1% of United States's total)
Key Insight: United States's per-shipment average of $247.4K (667% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Dasatinib imports from India.
2Canada
Canada ranks as the second-largest destination for Dasatinib imports from India, with a total trade value of $3.3M across 21 shipments — representing a 20.1% share of all Dasatinib exports. The average shipment value of $156.5K is above the global average of $32.3K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Dasatinib importers in Canada: TARO PHARMACEUTICALS INC is the largest buyer, accounting for 79.8% ($2.6M) of this market's total imports.
• TARO PHARMACEUTICALS INC — $2.6M (79.8% of Canada's total)
• DR REDDYS LABORATORIES CANADA INC — $363.3K (11.1% of Canada's total)
• DR. REDDYS LABORATORIES CANADA INC — $300.6K (9.1% of Canada's total)
Key Insight: Canada's per-shipment average of $156.5K (385% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Dasatinib imports from India.
3Australia
Australia ranks as the third-largest destination for Dasatinib imports from India, with a total trade value of $2.1M across 17 shipments — representing a 12.9% share of all Dasatinib exports. The average shipment value of $124.7K is above the global average of $32.3K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Dasatinib importers in Australia: SUN PHARMA ANZ PTY LTD. is the largest buyer, accounting for 32.2% ($682.5K) of this market's total imports.
• SUN PHARMA ANZ PTY LTD. — $682.5K (32.2% of Australia's total)
• SUN PHARMA ANZ PTY LTD — $678.4K (32.0% of Australia's total)
• DR REDDYS LABORATORIES (AUSTRALIA) — $364.5K (17.2% of Australia's total)
Key Insight: Australia's per-shipment average of $124.7K (287% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Dasatinib imports from India.
4Mexico
Mexico ranks as the fourth-largest destination for Dasatinib imports from India, with a total trade value of $1.7M across 8 shipments — representing a 10.4% share of all Dasatinib exports. The average shipment value of $212.3K is above the global average of $32.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Dasatinib importers in Mexico: MSN LIFE CARE SA DE CVRFC MLC170629 is the largest buyer, accounting for 99.8% ($1.7M) of this market's total imports.
• MSN LIFE CARE SA DE CVRFC MLC170629 — $1.7M (99.8% of Mexico's total)
Key Insight: Mexico's per-shipment average of $212.3K (558% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Mexico is a key market for Dasatinib imports from India.
5Belgium
Belgium ranks as the fifth-largest destination for Dasatinib imports from India, with a total trade value of $947.7K across 11 shipments — representing a 5.8% share of all Dasatinib exports. The average shipment value of $86.2K is above the global average of $32.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Dasatinib importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 100.0% ($947.7K) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $947.7K (100.0% of Belgium's total)
Key Insight: Belgium's per-shipment average of $86.2K (167% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Dasatinib imports from India.
People Also Ask — Dasatinib Supplier & Trade Network
Who are the top suppliers of Dasatinib from India?+
Which companies buy Dasatinib from Indian manufacturers?+
Where does Dasatinib exported from India go?+
What is the market share of the top Dasatinib supplier from India?+
What is the average shipment value for Dasatinib exports from India?+
Is Dasatinib manufactured in India and exported globally?+
Which country imports the most Dasatinib from India?+
Who are the buyers of Dasatinib in Canada?+
How concentrated is the Dasatinib supplier market in India?+
How do I find verified buyers for Dasatinib in specific countries?+
Dasatinib Trade Network — Key Takeaways
- 1DR.REDDY'S LABORATORIES LTD is India's dominant Dasatinib exporter with a 15.4% market share and $2.5M in total exports — making it the single most important sourcing entity in this market.
- 2The top 110 suppliers collectively account for 69.1% of all tracked Dasatinib exports, with a combined trade value of $16.4M.
- 3United States is the largest destination market, absorbing 31.7% of India's Dasatinib exports ($5.2M). Canada (20.1%) and Australia (12.9%) follow.
- 4With 508 total shipments averaging $32.3K each, the Dasatinib export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include DR REDDYS LABORARORIES, INC, DR. REDDYS LABORATORIES CANADA INC, MSN LIFE CARE SA DE CVRFC MLC170629, MSN LABS PERU SAC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 71 countries
Network value: $16.4M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Dasatinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Dasatinib.
- 2.Flow Mapping: 110 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 508 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 71 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
508 Verified Shipments
110 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists